Ileitis Secondary to Oral Capecitabine Treatment?
Joint Authors
Namelo, Wanangwa C.
Brewster, Alison E.
Robinson, Mark
Radwan, Rami
Williams, Gethin L.
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-11-26
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The efficacy of capecitabine as adjuvant therapy in colon cancer is well demonstrated and its lower toxicity rates when compared with 5-FU make it an increasingly more favourable option for patients.
This case highlights the awareness of a potentially severe side effect related to the use of capecitabine, yet through the early identification of symptoms patients can be managed conservatively.
American Psychological Association (APA)
Radwan, Rami& Namelo, Wanangwa C.& Robinson, Mark& Brewster, Alison E.& Williams, Gethin L.. 2012. Ileitis Secondary to Oral Capecitabine Treatment?. Case Reports in Medicine،Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-450222
Modern Language Association (MLA)
Radwan, Rami…[et al.]. Ileitis Secondary to Oral Capecitabine Treatment?. Case Reports in Medicine No. 2012 (2012), pp.1-3.
https://search.emarefa.net/detail/BIM-450222
American Medical Association (AMA)
Radwan, Rami& Namelo, Wanangwa C.& Robinson, Mark& Brewster, Alison E.& Williams, Gethin L.. Ileitis Secondary to Oral Capecitabine Treatment?. Case Reports in Medicine. 2012. Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-450222
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-450222
